PharmaBoardroom

Jean-Paul Scheuer, General Manager, Sanofi Genzyme MCO Lead, Gulf…

Jean Paul Scheuer, General Manager for Sanofi Genzyme and MCO Lead for Greater Gulf, highlights the company's expanding footprint in the region, the…

Mazen M. Hassanain – Co-Founder and Managing Director,…

SaudiVax intends to be the premier developer, manufacturer, and supplier of vaccines and biologics in Saudi Arabia and the MENA region, including…

Emmanuelle Lepine, CEO, mAbxience

mAbxience’s CEO Emmanuelle Lepine highlights the company’s international expansion into highly regulated markets, new investment into its Spanish…

PharmaBoardroom’s Top 5 Executive Insights 2021

2021 saw PharmaBoardroom’s network of executives and experts weighing in on some of the most pressing issues facing our industry today. See below…

Waleed Mohammed Al-Shaqha – Chairman of Board of Directors,…

Waleed Mohammed Al-Shaqha PharD PhD outlines the important role that API manufacturer CAD plays within Saudi Arabia, the importance of local…

EUnetHTA 21 Launches Joint Scientific Consultations for…

Writing in the December edition of DIA’s Global Forum magazine, Thomas Kühler updates his August piece on the progress towards a unified HTA…

Key Features of Orphan Drug Registration in Singapore, Malaysia,…

Writing in the December edition of DIA’s Global Forum magazine, Agnes Ho, Cindy Zen, and Tan Kwee Lan of Boehringer Ingelheim give an overview of…

The Cell & Gene Therapy Market: Excitement Abounds

David H. Crean, Managing General Partner for Coast BioVentures, updates and highlights the latest trends in the cell and gene therapy market for deal…

PharmaBoardroom’s Top Five Op-Eds of 2021

PharmaBoardroom's network of thought leaders provided some of our best-read content in 2021 on topics ranging from China's National Reimbursement Drug…